Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunoprecise Antibodies Ltd (NQ: IPA )

1.610 -0.060 (-3.59%)
Streaming Delayed Price Updated: 1:31 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 56,044
Open 1.640
Bid (Size) 1.610 (9)
Ask (Size) 1.640 (5)
Prev. Close 1.670
Today's Range 1.500 - 1.670
52wk Range 1.619 - 5.900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ImmunoPrecise Antibodies Announces CFO Transition
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
From ImmunoPrecise Antibodies Ltd.
Via Business Wire

Performance

YTD
-69.10%
-69.10%
1 Month
-30.90%
-30.90%
3 Month
-46.86%
-46.86%
6 Month
-36.11%
-36.11%
1 Year
-65.60%
-65.60%

More News

Read More
Earnings Outlook For ImmunoPrecise Antibodies
Via Benzinga
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies's Earnings Outlook
Via Benzinga
IPA Announces Board Refreshment
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA Responds to 13D Filing
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Invites Investors and Stakeholders to Exclusive Interview with Market Radius Research
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Earnings Scheduled For July 7, 2023
Via Benzinga
Costco, AZZ And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Investor Sentiment Drops Following Economic Reports
Via Benzinga
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
“Convergence of AI and Biology: Companies at the Forefront of Transformative Innovations”:- IPA, MRKR, PRAX , RMED
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
IPA’s Subsidiary BioStrand Unveils Use Case for Solving the Information Integration Dilemma (IID)
From ImmunoPrecise Antibodies
Via Business Wire
Healthcare and AI “Paradigm Shift” Stocks in Focus: IPA, MGRX, INBS, RMED
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) Is Strategically Built To Advance The Future
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market
From ImmunoPrecise Antibodies
Via Business Wire
IPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems Biology
From ImmunoPrecise Antibodies
Via Business Wire
IPA to Present at Jefferies Healthcare Conference 2023
From ImmunoPrecise Antibodies
Via Business Wire
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The Street Reports: NASDAQ Stocks Poised to Disrupt the Markets: IPA, RELI, SKYX, AZ
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
TheStreetReports: AI Biotech Stocks to Watch 2023: IPA, ONTX, AGEN, PBIO
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
ImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with Astellas
From ImmunoPrecise Antibodies
Via Business Wire
European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology
From ImmunoPrecise Antibodies
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.